| advertisment
DIA 2016 brings together global thought leaders and innovators - from industry, academia, regulatory and government agencies, health, patient, and philanthropic organizations - conversing about the future of therapeutics, and how they affect you.
 Click here
|
|
|
|
news roundup
In face of using combination immunotherapies, coalition will speed the traditional—read slow—path of drug development.
The 44-bed clinic will use eConsent and serve as a gateway to Latin America.
The global biosimulation technology-enabled drug development company, announced the launch of Certara Strategic Consulting China in Shanghai.
Latest people moves, business announcements and recognition from companies around the globe.
|
|
|
Subscribe
|
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
|
|
Advertisment
|
|
|
articles
Patient reported outcomes involve a new set of conditions that, for some therapy areas, were previously relegated to post-approval or marketing trials only.
|
|
Blog Posts
Survey shows a need for clin ops to understand that endpoint adjudication technologies do exist.
|
|
|
Regulatory Update
Legacy systems may not be equipped to handle the data needs that regulators are requiring for clinical trials data disclosure.
The news that the horizon for the clinical trial rules had shifted to October 2018 has provoked sharp reactions among those battling with the incoherencies of the EU's current rules on clinical trials.
Califf maintains it isn't just who is included in the trials, but how diverse populations are included in the design of the trials and to identify what is important to them.
|
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
|
|
